| Primary |
| Product Used For Unknown Indication |
36.0% |
| Acne |
11.1% |
| Drug Use For Unknown Indication |
6.4% |
| Lower Respiratory Tract Infection |
5.0% |
| Rosacea |
4.2% |
| Upper Respiratory Tract Infection |
4.2% |
| Malaria Prophylaxis |
3.6% |
| Staphylococcal Infection |
3.6% |
| Infection |
3.4% |
| Lyme Disease |
3.1% |
| Urinary Tract Infection |
3.0% |
| Sinusitis |
2.8% |
| Device Related Infection |
2.1% |
| Vaginal Infection |
1.9% |
| Pneumonia |
1.7% |
| Prophylaxis |
1.7% |
| Tenosynovitis |
1.7% |
| Prostatitis |
1.6% |
| Cellulitis |
1.4% |
| Hypertension |
1.2% |
|
| Vomiting |
13.8% |
| Rash |
8.3% |
| Stevens-johnson Syndrome |
7.4% |
| Oesophageal Ulcer |
6.4% |
| Nausea |
5.2% |
| Pancreatitis Acute |
5.2% |
| Photosensitivity Reaction |
5.2% |
| Pancreatitis |
4.6% |
| Urticaria |
4.3% |
| Weight Decreased |
4.3% |
| Paraesthesia |
4.0% |
| Vision Blurred |
4.0% |
| Alopecia |
3.7% |
| Drug Hypersensitivity |
3.7% |
| Toxic Shock Syndrome |
3.7% |
| Headache |
3.4% |
| Oesophagitis |
3.4% |
| Pruritus |
3.4% |
| Drug Ineffective |
3.1% |
| Pyrexia |
3.1% |
|
| Secondary |
| Product Used For Unknown Indication |
39.0% |
| Drug Use For Unknown Indication |
10.9% |
| Rosacea |
5.7% |
| Hypertension |
4.3% |
| Lower Respiratory Tract Infection |
4.1% |
| Acne |
3.2% |
| Tenosynovitis |
3.2% |
| Lyme Disease |
3.0% |
| Depression |
2.8% |
| Pain |
2.8% |
| Infection |
2.6% |
| Urinary Tract Infection |
2.4% |
| Foetal Exposure During Pregnancy |
2.3% |
| Pneumonia |
2.3% |
| Ill-defined Disorder |
2.0% |
| Non-small Cell Lung Cancer |
1.9% |
| Prophylaxis |
1.9% |
| Whipple's Disease |
1.9% |
| Antifungal Prophylaxis |
1.8% |
| Anxiety |
1.8% |
|
| Vomiting |
13.7% |
| Drug Hypersensitivity |
8.8% |
| Rash |
8.4% |
| Toxic Epidermal Necrolysis |
6.6% |
| Weight Decreased |
5.3% |
| Vision Blurred |
4.9% |
| Jaundice Cholestatic |
4.4% |
| Urticaria |
4.4% |
| White Blood Cell Count Increased |
4.4% |
| Pneumonia |
4.0% |
| Renal Failure |
4.0% |
| Small Intestinal Perforation |
4.0% |
| Urinary Tract Infection |
4.0% |
| Nausea |
3.5% |
| Suicide Attempt |
3.5% |
| Swollen Tongue |
3.5% |
| Cytomegalovirus Infection |
3.1% |
| Diarrhoea |
3.1% |
| Pyrexia |
3.1% |
| Renal Impairment |
3.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
33.5% |
| Drug Use For Unknown Indication |
11.7% |
| Abortion Induced |
9.0% |
| Acne |
6.4% |
| Pain |
5.1% |
| Hypertension |
4.3% |
| Depression |
3.5% |
| Rheumatoid Arthritis |
3.1% |
| Contraception |
2.6% |
| Gastrooesophageal Reflux Disease |
2.4% |
| Anxiety |
2.2% |
| Asthma |
2.1% |
| Multiple Myeloma |
2.0% |
| Prophylaxis |
1.9% |
| Non-small Cell Lung Cancer |
1.9% |
| Diabetes Mellitus |
1.8% |
| Nausea |
1.8% |
| Chronic Obstructive Pulmonary Disease |
1.7% |
| Constipation |
1.7% |
| Crohn's Disease |
1.6% |
|
| Haemorrhage |
16.6% |
| Vomiting |
11.2% |
| Abortion Incomplete |
7.5% |
| Pregnancy |
7.3% |
| Weight Decreased |
7.1% |
| Pain |
6.5% |
| Pulmonary Embolism |
5.3% |
| Syncope |
4.1% |
| Pyrexia |
4.0% |
| Weight Increased |
3.9% |
| Menorrhagia |
3.6% |
| Nausea |
2.9% |
| Muscle Spasms |
2.8% |
| Rash |
2.7% |
| White Blood Cell Count Decreased |
2.7% |
| Anaemia |
2.6% |
| Pneumonia |
2.5% |
| Somnolence |
2.3% |
| Death |
2.2% |
| Vision Blurred |
2.1% |
|
| Interacting |
| Hypertension |
36.9% |
| Anxiety |
13.3% |
| Depression |
13.3% |
| Product Used For Unknown Indication |
12.4% |
| Infection |
10.4% |
| Lower Respiratory Tract Infection |
2.1% |
| Metastatic Malignant Melanoma |
1.7% |
| Renal Impairment |
1.7% |
| Trigeminal Neuralgia |
1.7% |
| Drug Use For Unknown Indication |
0.8% |
| Epilepsy |
0.8% |
| Facial Palsy |
0.8% |
| Furuncle |
0.8% |
| Smoking Cessation Therapy |
0.8% |
| Acne |
0.4% |
| Blood Calcium Increased |
0.4% |
| Blood Cholesterol Increased |
0.4% |
| Contraception |
0.4% |
| Convulsion |
0.4% |
| Diabetes Mellitus |
0.4% |
|
| Mobility Decreased |
47.7% |
| Drug Interaction |
22.7% |
| Cholestasis |
4.5% |
| Pyrexia |
4.5% |
| Drug Level Increased |
2.3% |
| Epilepsy |
2.3% |
| International Normalised Ratio Increased |
2.3% |
| Metrorrhagia |
2.3% |
| Pancreatitis |
2.3% |
| Serum Ferritin Increased |
2.3% |
| Skin Exfoliation |
2.3% |
| Toxic Shock Syndrome |
2.3% |
| Vomiting |
2.3% |
|
